We are the best strategic partner to lead innovative drugs
from EU approval to national P&R and Market Access in Spain,
specialised in oncology, orphan drugs and Advanced Therapies (ATMPs)

We are the best strategic partner to lead
innovative drugs from EU approval
to national P&R and Market Access in Spain,
specialised in oncology, orphan drugs
and Advanced Therapies (ATMPs)

neo2020-09-10T10:26:51+00:00

WHAT WE DO

We offer strategic support to companies during the drugs’ full lifecycle: from the regulatory process, including the Therapeutic Positioning Report (TPR) development to P&R submission, negotiation and approval, and Market Access at regional and hospital level. We do so by collaborating with relevant stakeholders, scientific societies and patients associations to ensure a successful Pricing and Market Access for innovative drugs in Spain.

OMAKASE LEADERSHIP TEAM

 ALICIA GIL
ALICIA GILPARTNER & CEO
XAVIER BADIA
XAVIER BADIAPARTNER & CEO

PUBLICATIONS

NEWS & EVENTS

GET IN TOUCH

CONTACT INFO

BARCELONA & MADRID OFFICES

Telephone: +34 674614704 | +34 931890969

E-mail: administracion@omakaseconsulting.com

APPLY FOR A JOB

Please send your CV to: administracion@omakaseconsulting.com

Follow Us On Social Media!